Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Notes Payables: 2023-2024

  • Biofrontera's Notes Payables was N/A to $296,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $296,000, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2023, which is N/A change from last year.
  • Biofrontera's Notes Payables amounted to $296,000 in Q2 2024, which was down 87.43% from $2.4 million recorded in Q1 2024.
  • Biofrontera's 5-year Notes Payables high stood at $3.9 million for Q4 2023, and its period low was $296,000 during Q2 2024.
  • In the last 2 years, Biofrontera's Notes Payables had a median value of $2.4 million in 2024 and averaged $2.2 million.